Your browser doesn't support javascript.
loading
CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site.
Clevestig, Peter; Pramanik, Lotta; Leitner, Thomas; Ehrnst, Anneka.
Affiliation
  • Clevestig P; Microbiology and Tumor Biology Center, Karolinska Institutet, Box 280, SE-171 77 Stockholm, Sweden.
  • Pramanik L; Microbiology and Tumor Biology Center, Karolinska Institutet, Box 280, SE-171 77 Stockholm, Sweden.
  • Leitner T; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
  • Ehrnst A; Department of Laboratory Medicine, Division of Clinical Virology, Karolinska University Hospital Huddinge, Karolinska Institutet, Box 280, SE-171 77 Stockholm, Sweden.
J Gen Virol ; 87(Pt 3): 607-612, 2006 Mar.
Article in En | MEDLINE | ID: mdl-16476981
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp120 / HIV-1 / Receptors, CCR5 Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Gen Virol Year: 2006 Document type: Article Affiliation country: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp120 / HIV-1 / Receptors, CCR5 Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Gen Virol Year: 2006 Document type: Article Affiliation country: Sweden